C21 Investments Past Earnings Performance
Past criteria checks 0/6
Key information
53.2%
Earnings growth rate
68.5%
EPS growth rate
Pharmaceuticals Industry Growth | 23.1% |
Revenue growth rate | 11.9% |
Return on equity | -7.7% |
Net Margin | -8.9% |
Last Earnings Update | 31 Oct 2023 |
Recent past performance updates
Recent updates
Some Confidence Is Lacking In C21 Investments Inc. (CSE:CXXI) As Shares Slide 27%
Mar 09Is C21 Investments (CSE:CXXI) A Risky Investment?
Sep 04These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well
Mar 21These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well
Nov 29C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Oct 12A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)
Apr 22Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?
Mar 22C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations
Oct 05We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt
Sep 03C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly
Mar 07Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow C21 Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Oct 23 | 29 | -3 | 6 | 0 |
31 Jul 23 | 29 | -2 | 6 | 0 |
30 Apr 23 | 29 | 0 | 6 | 0 |
31 Jan 23 | 29 | 1 | 6 | 0 |
31 Oct 22 | 30 | 3 | 6 | 0 |
31 Jul 22 | 30 | 6 | 6 | 0 |
30 Apr 22 | 32 | 8 | 6 | 0 |
31 Jan 22 | 33 | 12 | 6 | 0 |
31 Oct 21 | 32 | 8 | 8 | 0 |
31 Jul 21 | 33 | 8 | 9 | 0 |
30 Apr 21 | 34 | 2 | 8 | 0 |
31 Jan 21 | 33 | -5 | 9 | 0 |
31 Oct 20 | 36 | -22 | 7 | 0 |
31 Jul 20 | 38 | -29 | 7 | 0 |
30 Apr 20 | 38 | -31 | 10 | 0 |
31 Jan 20 | 38 | -33 | 11 | 0 |
31 Oct 19 | 30 | -23 | 9 | 0 |
31 Jul 19 | 20 | -21 | 10 | 0 |
30 Apr 19 | 10 | -26 | 14 | 0 |
31 Jan 19 | 3 | -24 | 12 | 0 |
31 Oct 18 | 0 | -12 | 11 | 0 |
31 Jul 18 | 0 | -9 | 9 | 0 |
30 Apr 18 | 0 | -2 | 1 | 0 |
31 Jan 18 | 0 | -1 | 1 | 0 |
31 Oct 17 | 0 | 0 | 0 | 0 |
31 Jul 17 | 0 | 0 | 0 | 0 |
30 Apr 17 | 0 | 0 | 0 | 0 |
31 Jan 17 | 0 | 0 | 0 | 0 |
31 Oct 16 | 0 | 0 | 0 | 0 |
31 Jul 16 | 0 | 0 | 0 | 0 |
30 Apr 16 | 0 | 0 | 0 | 0 |
31 Jan 16 | 0 | 0 | 0 | 0 |
31 Oct 15 | 0 | 0 | 0 | 0 |
31 Jul 15 | 0 | 0 | 0 | 0 |
30 Apr 15 | 0 | 0 | 0 | 0 |
31 Jan 15 | 0 | 0 | 0 | 0 |
31 Oct 14 | 0 | 0 | 0 | 0 |
31 Jul 14 | 0 | 0 | 0 | 0 |
30 Apr 14 | 0 | 0 | 0 | 0 |
31 Jan 14 | 0 | 0 | 0 | 0 |
31 Oct 13 | 0 | 0 | 0 | 0 |
31 Jul 13 | 0 | 0 | 0 | 0 |
Quality Earnings: CXXI is currently unprofitable.
Growing Profit Margin: CXXI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CXXI is unprofitable, but has reduced losses over the past 5 years at a rate of 53.2% per year.
Accelerating Growth: Unable to compare CXXI's earnings growth over the past year to its 5-year average as it is currently unprofitable